ArticleNutrients2025
Isorhamnetin Exhibits Hypoglycemic Activity and Targets PI3K/AKT and COX-2 Pathways in Type 1 Diabetes.
Lijia Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleNutrients2025
Lijia Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.